172 related articles for article (PubMed ID: 38408140)
21. Abdominal desmoplastic small round cell tumor: multimodal treatment combining chemotherapy, surgery, and radiotherapy is the best option.
Honoré C; Amroun K; Vilcot L; Mir O; Domont J; Terrier P; Le Cesne A; Le Péchoux C; Bonvalot S
Ann Surg Oncol; 2015 Apr; 22(4):1073-9. PubMed ID: 25300608
[TBL] [Abstract][Full Text] [Related]
22. Advanced intrahepatic cholangiocarcinoma treated using anlotinib and microwave ablation: A case report.
Zhang A; Liu B; Xu D; Sun Y
Medicine (Baltimore); 2019 Dec; 98(52):e18435. PubMed ID: 31876723
[TBL] [Abstract][Full Text] [Related]
23. Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development.
Shen G; Zheng F; Ren D; Du F; Dong Q; Wang Z; Zhao F; Ahmad R; Zhao J
J Hematol Oncol; 2018 Sep; 11(1):120. PubMed ID: 30231931
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Abdominal Desmoplastic Small Round Cell Tumor Induces Acute Myeloid Leukemia-M5: A Case Report and Literature Review.
Liu L; Zhong M; Zhou X; Kang F; Long Y; Li J
Onco Targets Ther; 2024; 17():163-169. PubMed ID: 38435840
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy combined with apatinib for the treatment of desmoplastic small round cell tumors: A case report.
Tian Y; Cheng X; Li Y
J Cancer Res Ther; 2020 Sep; 16(5):1177-1181. PubMed ID: 33004767
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and outcomes of 20 patients with abdominopelvic desmoplastic small round cell tumor.
Angarita FA; Hassan S; Cannell AJ; Dickson BC; Gladdy RA; Swallow CJ; Gupta A; Blackstein ME; McCart JA
Eur J Surg Oncol; 2017 Feb; 43(2):423-431. PubMed ID: 27890349
[TBL] [Abstract][Full Text] [Related]
27. A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer.
Cui Q; Hu Y; Ma D; Liu H
Drug Des Devel Ther; 2021; 15():339-347. PubMed ID: 33536747
[TBL] [Abstract][Full Text] [Related]
28. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer.
Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Chen Y; Zhou J; Wang D
Lung Cancer; 2018 Aug; 122():32-37. PubMed ID: 30032842
[TBL] [Abstract][Full Text] [Related]
29. China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy.
Zhou M; Chen X; Zhang H; Xia L; Tong X; Zou L; Hao R; Pan J; Zhao X; Chen D; Song Y; Qi Y; Tang L; Liu Z; Gao R; Shi Y; Yang Z
Cancer Commun (Lond); 2019 Jun; 39(1):36. PubMed ID: 31221221
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features of desmoplastic small round cell tumors: clinical series and literature review.
Wang LL; Ji ZH; Gao Y; Chang H; Sun PP; Li Y
World J Surg Oncol; 2021 Jun; 19(1):193. PubMed ID: 34193155
[TBL] [Abstract][Full Text] [Related]
31. Effective treatment of anlotinib in giant delayed pulmonary metastasis of osteosarcoma: a case report and literature review.
Long ZY; Lu Y; Li M; Chen G; Shi L; Xiao X; Bai Y; Zhang HM; Wang Z
Ann Palliat Med; 2021 Jun; 10(6):7073-7082. PubMed ID: 33548989
[TBL] [Abstract][Full Text] [Related]
32. Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review.
Reijers SJM; Siew CCH; Kok NFM; Honoré C; van Houdt WJ
Curr Oncol; 2023 Mar; 30(4):3951-3963. PubMed ID: 37185412
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor.
Slotkin EK; Bowman AS; Levine MF; Dela Cruz F; Coutinho DF; Sanchez GI; Rosales N; Modak S; Tap WD; Gounder MM; Thornton KA; Bouvier N; You D; Gundem G; Gerstle JT; Heaton TE; LaQuaglia MP; Wexler LH; Meyers PA; Kung AL; Papaemmanuil E; Zehir A; Ladanyi M; Shukla N
Mol Cancer Res; 2021 Jul; 19(7):1146-1155. PubMed ID: 33753552
[TBL] [Abstract][Full Text] [Related]
34. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
Wang G; Sun M; Jiang Y; Zhang T; Sun W; Wang H; Yin F; Wang Z; Sang W; Xu J; Mao M; Zuo D; Zhou Z; Wang C; Fu Z; Wang Z; Duan Z; Hua Y; Cai Z
Int J Cancer; 2019 Aug; 145(4):979-993. PubMed ID: 30719715
[TBL] [Abstract][Full Text] [Related]
35. Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial.
Han B; Li K; Wang Q; Zhang L; Shi J; Wang Z; Cheng Y; He J; Shi Y; Zhao Y; Yu H; Zhao Y; Chen W; Luo Y; Wu L; Wang X; Pirker R; Nan K; Jin F; Dong J; Li B; Sun Y
JAMA Oncol; 2018 Nov; 4(11):1569-1575. PubMed ID: 30098152
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the diagnosis and treatment of desmoplastic small round cell tumor].
Lu B; Zhang W; Shang Z; Sun E; Nian X; Gao J; Ma C; Han R
Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):686-90. PubMed ID: 26813434
[TBL] [Abstract][Full Text] [Related]
37. Anlotinib Combined with S-1 in Third- or Later-Line Stage IV Non-Small Cell Lung Cancer Treatment: A Phase II Clinical Trial.
Xiang M; Yang X; Ren S; Du H; Geng L; Yuan L; Wen Y; Lin B; Li J; Zhang Y; Feng G; Du X
Oncologist; 2021 Dec; 26(12):e2130-e2135. PubMed ID: 34423518
[TBL] [Abstract][Full Text] [Related]
38. Anlotinib or platinum-pemetrexed as second-line therapy in EGFR T790M-negative lung cancer.
Zhong RB; Xu JL; Lou YQ; Chu TQ; Zhong H; Han BH
Ann Palliat Med; 2020 Jul; 9(4):1681-1687. PubMed ID: 32575999
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib.
Chen D; Xu J; Zhao Y; Chu T; Zhong H; Han B; Zhong R
J Cancer Res Clin Oncol; 2020 Feb; 146(2):401-406. PubMed ID: 31691871
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non-Small-Cell Lung Cancer After Previous Systemic Treatment Failure-A Retrospective Study.
Wang P; Fang X; Yin T; Tian H; Yu J; Teng F
Front Oncol; 2021; 11():628124. PubMed ID: 33791214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
